DPW - Ault Global Holdings to buy 40% equity interest in Adtech Pharma

Ault Global Holdings (DPW) enters a securities purchase contract to acquire up to 40% of the current equity in Adtech Pharma, a biotechnology company, for $3 million.The investment in Adtech is through Digital Power Lending, LLC, a wholly-owned subsidiary of the Ault Global.Highlights regarding Adtech and NB-110, a novel ophthalmic formulation: NB-110 comprises of a synthetic cannabinoid Nabilone in the absence of any preservative and its formulation mimics a human tear to drive efficacious delivery through the cornea to the retina and optical nerves in the back of eye; Adtech will own the USPTO registered intellectual property in composition, method of manufacturing and use; the Company notes that, to date, no company has demonstrated in clinical trials that natural cannabinoids are efficacious for glaucoma despite anecdotal evidence, and Synthetic Nabilone is a cannabinoid receptor agonist, a crystalline, and is stable under heat, light and oxygen, an advantage over natural occurring

For further details see:

Ault Global Holdings to buy 40% equity interest in Adtech Pharma